ahlam1399
06-18-2015, 01:06 AM
BioMarin?s dwarfism treatment improves growth in mid-stage study
June 17 (Reuters) - BioMarin Pharmaceutical Inc said its experimental drug was effective in improving growth in children with the most common form of dwarfism in a mid-stage study. http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=xZMV-SmsFTA:CUUDtHhkoIg:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=xZMV-SmsFTA:CUUDtHhkoIg:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=xZMV-SmsFTA:CUUDtHhkoIg:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=xZMV-SmsFTA:CUUDtHhkoIg:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=xZMV-SmsFTA:CUUDtHhkoIg:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/xZMV-SmsFTA
June 17 (Reuters) - BioMarin Pharmaceutical Inc said its experimental drug was effective in improving growth in children with the most common form of dwarfism in a mid-stage study. http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=xZMV-SmsFTA:CUUDtHhkoIg:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=xZMV-SmsFTA:CUUDtHhkoIg:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=xZMV-SmsFTA:CUUDtHhkoIg:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=xZMV-SmsFTA:CUUDtHhkoIg:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=xZMV-SmsFTA:CUUDtHhkoIg:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/xZMV-SmsFTA